Cullinan Therapeutics, Inc. ( CGEM) - Key Metrics
CGEM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.87 | -$0.62 | -$0.62 |
| 2026Q1 | $0 | -$0.84 | -$0.78 | -$0.78 |
| 2025Q4 | $0 | -$0.86 | -$0.64 | -$0.64 |
| 2025Q3 | $0 | -$0.86 | -$0.62 | -$0.63 |
| 2025Q2 | $0 | -$1.19 | -$0.98 | -$0.98 |
CGEM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -5.62 |
| 2026Q1 | 0% | -4.23 |
| 2025Q4 | 0% | -3.01 |
| 2025Q3 | 0% | -1.72 |
| 2025Q2 | 0% | -1.58 |
CGEM
Price: $20.34
52 week price:
Earnings Per Share: -3.11 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 351200
Market Capitalization: 1.2 billion